Technological Discontinuities and the Comparative Strategic Value of New Capabilites: Evidence from the Comparison of Small- and Large-Molecule Targeted Anti-Cancer Drug Discovery
作者： M. Lourdes Sosa
DOI:
关键词:
摘要: Traditional creative destruction theories distinguish disruptions as competence-destroying or competence-enhancing to incumbents’ capabilities, with the former case resulting in loss of competitive advantage in-house RD but they fell behind biopharmaceutical technology pioneers large-molecule targeted drug discovery, where one new capabilities (i.e., expertise technology) had higher value added and was more difficult acquire than other capabilities.
参考文章(30)
David J Teece, Gary Pisano, Amy Shuen, None, DYNAMIC CAPABILITIES AND STRATEGIC MANAGEMENT Strategic Management Journal. ,vol. 18, pp. 509- 533 ,(1997) , 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z
James W. Fisher, A QUEST FOR ERYTHROPOIETIN OVER NINE DECADES Annual Review of Pharmacology and Toxicology. ,vol. 38, pp. 1- 20 ,(1998) , 10.1146/ANNUREV.PHARMTOX.38.1.1
Louis Rosenfeld, Insulin: Discovery and Controversy Clinical Chemistry. ,vol. 48, pp. 2270- 2288 ,(2002) , 10.1093/CLINCHEM/48.12.2270
David J. Teece, ECONOMIES OF SCOPE AND THE SCOPE OF THE ENTERPRISE Journal of Economic Behavior and Organization. ,vol. 1, pp. 223- 247 ,(1980) , 10.1016/0167-2681(80)90002-5
Bruce Kogut, Udo Zander, Knowledge of the Firm, Combinative Capabilities, and the Replication of Technology Organization Science. ,vol. 3, pp. 383- 397 ,(1992) , 10.1287/ORSC.3.3.383
Robert Bazell, Her-2: the making of herceptin, a revolutionary treatment for breast cancer ,(1998)
Sendil K. Ethiraj, Prashant Kale, M. S. Krishnan, Jitendra V. Singh, Where do capabilities come from and how do they matter? A study in the software services industry Strategic Management Journal. ,vol. 26, pp. 25- 45 ,(2005) , 10.1002/SMJ.433
Rebecca Henderson, Luigi Orsenigo, Gary P. Pisano, The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change Cambridge University Press. pp. 267- 311 ,(1999) , 10.1017/CBO9781139175128.007
Maryann Feldman, The Locational Dynamics of the U.S. Biotech Industry: Knowledge Externalities and the Anchor Hypothesis Industry and Innovation. ,vol. 10, pp. 201- 224 ,(2005) , 10.1007/3-7908-1658-2_9
Giovanni Dosi, Technological paradigms and technological trajectories: A suggested interpretation of the determinants and directions of technical change Research Policy. ,vol. 11, pp. 147- 162 ,(1982) , 10.1016/0048-7333(82)90016-6